The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1581
ISSUE1581
September 23, 2019
Qmiiz ODT - An Orally Disintegrating Meloxicam Tablet
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Qmiiz ODT - An Orally Disintegrating Meloxicam Tablet
September 23, 2019 (Issue: 1581)
The FDA has approved Qmiiz ODT (TerSera), an orally
disintegrating tablet formulation of the prescription
NSAID meloxicam. Qmiiz ODT, like conventional oral
meloxicam tablets (Mobic, and generics), is indicated
for relief of the symptoms of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.